Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing cetylpyridinium (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetylpyridinium |
Inferred relationship |
Some |
1 |
Cetylpyridinium adverse reaction |
Causative agent |
True |
Cetylpyridinium |
Inferred relationship |
Some |
1 |
Allergy to cetylpyridinium (finding) |
Causative agent |
False |
Cetylpyridinium |
Inferred relationship |
Some |
|
cetylpyridiniumchlorid 0,066 % sugetablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cetylpyridinium |
Inferred relationship |
Some |
|
cetylpyridiniumchlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cetylpyridinium |
Inferred relationship |
Some |
|
cetylpyridiniumchlorid + ascorbinsyre |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cetylpyridinium |
Inferred relationship |
Some |
|
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cetylpyridinium |
Inferred relationship |
Some |
|
Cetylpyridinium chloride (substance) |
Is a |
False |
Cetylpyridinium |
Inferred relationship |
Some |
|
Product containing precisely cetylpyridinium chloride 1 milligram/1 gram and lidocaine hydrochloride 3.3 milligram/1 gram conventional release dental gel (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cetylpyridinium |
Inferred relationship |
Some |
|
Product containing cetylpyridinium and lidocaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetylpyridinium |
Inferred relationship |
Some |
1 |
Product containing cetylpyridinium and guaifenesin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetylpyridinium |
Inferred relationship |
Some |
1 |
Product containing cetylpyridinium and menthol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetylpyridinium |
Inferred relationship |
Some |
1 |
Product containing benzocaine and cetylpyridinium (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetylpyridinium |
Inferred relationship |
Some |
1 |
Product containing cetylpyridinium in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetylpyridinium |
Inferred relationship |
Some |
1 |
Product containing cetylpyridinium in oropharyngeal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cetylpyridinium |
Inferred relationship |
Some |
1 |
Allergy to cetylpyridinium (finding) |
Causative agent |
True |
Cetylpyridinium |
Inferred relationship |
Some |
1 |
Cetylpyridinium chloride (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Cetylpyridinium |
Inferred relationship |
Some |
|
Product containing ascorbic acid and cetylpyridinium (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetylpyridinium |
Inferred relationship |
Some |
1 |
Benzocaine- and cetylpyridinium-containing product in oromucosal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetylpyridinium |
Inferred relationship |
Some |
1 |
Cetylpyridinium- and lidocaine-containing product in dental dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetylpyridinium |
Inferred relationship |
Some |
1 |
Cetylpyridinium only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetylpyridinium |
Inferred relationship |
Some |
1 |
Cetylpyridinium and lidocaine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetylpyridinium |
Inferred relationship |
Some |
1 |
Product containing only benzocaine and cetylpyridinium (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetylpyridinium |
Inferred relationship |
Some |
1 |
Product containing only cetylpyridinium and guaifenesin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetylpyridinium |
Inferred relationship |
Some |
1 |
Ascorbic acid and cetylpyridinium only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetylpyridinium |
Inferred relationship |
Some |
1 |
Product containing only cetylpyridinium and menthol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetylpyridinium |
Inferred relationship |
Some |
1 |
Benzocaine and cetylpyridinium only product in oromucosal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetylpyridinium |
Inferred relationship |
Some |
1 |
Cetylpyridinium and lidocaine only product in dental dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetylpyridinium |
Inferred relationship |
Some |
1 |
Cetylpyridinium only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetylpyridinium |
Inferred relationship |
Some |
1 |
Cetylpyridinium only product in oromucosal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetylpyridinium |
Inferred relationship |
Some |
1 |
Product containing cetylpyridinium in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetylpyridinium |
Inferred relationship |
Some |
1 |
Benzydamine and cetylpyridinium only product in oromucosal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetylpyridinium |
Inferred relationship |
Some |
1 |
Benzydamine and cetylpyridinium only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetylpyridinium |
Inferred relationship |
Some |
1 |
Product containing benzydamine and cetylpyridinium (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetylpyridinium |
Inferred relationship |
Some |
1 |
Product containing benzydamine and cetylpyridinium in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetylpyridinium |
Inferred relationship |
Some |
1 |
Product containing cetylpyridinium and chlorocresol and lidocaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetylpyridinium |
Inferred relationship |
Some |
2 |
Cetylpyridinium and chlorocresol and lidocaine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetylpyridinium |
Inferred relationship |
Some |
2 |
Product containing cetylpyridinium and chlorocresol and lidocaine in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetylpyridinium |
Inferred relationship |
Some |
2 |
Cetylpyridinium and chlorocresol and lidocaine only product in oromucosal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetylpyridinium |
Inferred relationship |
Some |
2 |